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Abstract
Noninvasive estimation of systolic pulmonary artery pressure (SPAP) during exercise stress echocardiography (ESE) is 
recommended for pulmonary hemodynamics evaluation but remains flow-dependent. Our aim was to assess the feasibil-
ity of pulmonary vascular reserve index (PVRI) estimation during ESE combining SPAP with cardiac output (CO) or 
exercise-time and compare its value in three group of patients: with invasively confirmed pulmonary hypertension (PH), at 
risk of PH development (PH risk) mainly with systemic sclerosis and in controls (C) without clinical risk factors for PH, 
age-matched with PH risk patients. We performed semisupine ESE in 171 subjects: 31 PH, 61 PH at risk and 50 controls 
as well as in 29 young, healthy normals. Rest and stress assessment included: tricuspid regurgitant flow velocity (TRV), 
pulmonary acceleration time (ACT), CO (Doppler-estimated). SPAP was calculated from TRV or ACT when TRV was not 
available. We estimated PVRI based on CO (peak CO/SPAP*0.1) or exercise-time (ESE time/SPAP*0.1). During stress, 
TRV was measurable in 44% patients ACT in 77%, either one in 95%. PVRI was feasible in 65% subjects with CO and 95% 
with exercise-time (p < 0.0001). PVRI was lower in PH compared to controls both for CO-based PVRI (group 1 = 1.0 ± 0.95 
vs group 3 = 4.28 ± 2.3, p < 0.0001) or time-based PVRI estimation (0.66 ± 0.39 vs 3.95 ± 2.26, p < 0.0001). The proposed 
criteria for PH detection were for CO-based PVRI ≤ 1.29 and ESE-time based PVRI ≤ 1.0 and for PH risk ≤ 1.9 and ≤ 1.7 
respectively. Noninvasive estimation of PVRI can be obtained in near all patients during ESE, without contrast administra-
tion, integrating TRV with ACT for SPAP assessment and using exercise time as a proxy of CO. These indices allow for 
comparison of pulmonary vascular dynamics in patients with varied exercise tolerance and clinical status.
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Abbreviations
ACT  Acceleration time of physiologic sys-
tolic forward pulmonary flow velocity
CO  Cardiac output
CO/SPAP  CO based pulmonary vascular reserve 
index
ESE  Exercise stress echocardiography
ESE time/SPAP  ESE time based pulmonary vascular 
reserve index
PAH  Pulmonary arterial hypertension
PH  Pulmonary hypertension
PVRI  Pulmonary vascular reserve index
RAP  Right atrial pressure
SPAP  Systolic pulmonary artery pressure
TRACT  Acronym for using TRV and ACT for 
SPAP estimation
TRV  Tricuspid regurgitant velocity
TTE  Transthoracic echocardiography
Introduction
The disproportionate increase in pulmonary artery pres-
sure during exercise is probably a precursor to pulmonary 
hypertension (PH) at rest [1, 2]. The early detection of PH 
is especially important in patients belonging to group 1 by 
the updated clinical classification of PH, including relatives 
of patients with diagnosed PAH (pulmonary arterial hyper-
tension) as well as PH associated to other diseases such as 
systemic sclerosis [1–4]. These patients presents high risk of 
PH development, assessed for 8% to 12%, and earlier therapy 
may improve their outcomes [5].
Nevertheless, noninvasive, echocardiographic assess-
ment of systolic arterial pulmonary pressure (SPAP) has 
the intrinsic limitation of being flow-dependent and in such 
a way by definition workload- related [1]. In spite of the 
many advantages as a noninvasive, available, radiation-
free technique, the use of exercise stress echocardiography 
(ESE) has remained limited to date, mostly for technical 
problems of sampling tricuspid regurgitant velocity (TRV) 
during exercise [6] and the conceptual limitation of estimat-
ing pulmonary hemodynamics with a flow-dependent index 
such as SPAP, loosing moreover its close relationship with 
pulmonary pressure in most advanced tricuspid regurgita-
tion [1–7]. The feasibility problem of TRV may, however, 
be minimized by measuring the acceleration time (ACT) of 
physiologic forward systolic pulmonary flow velocity, also 
present when TRV is unfeasible and estimating SPAP with 
a combined TRACT (tricuspid regurgitation + acceleration 
time) approach [8, 9].
The feature of pathologic increase of SPAP during exer-
cise is its disproportion to the cardiac output (CO) aug-
mentation and abnormal response of pulmonary vascular 
resistance. It has been estimated that normal pulmonary 
vascular response is related with the increase of mean pul-
monary arterial pressure in the range of 1–2 mmHg per 1 l/
min augmentation of CO [10]. Recently, the noninvasive 
assessment of similar parameter was proposed since the CO 
can be estimated from 2D volumetric echocardiography or 
preferably by Doppler, or even through the proxy of minutes 
of exercise [11].
The hypothesis of the present study is that in its refined 
version, ESE can solve the two major problems of subopti-
mal success rate for SPAP estimation as well as the limited 
discriminatory capacity of flow-dependent parameters.
The primary aim of our study was to assess in a mul-
ticenter, prospective design the feasibility of pulmonary 
vascular reserve index (PVRI) based either on CO (CO/
SPAP*0.1 at peak stress) or on simpler, imaging-independ-
ent exercise time (ESE time/SPAP*0.1 at peak stress). The 
secondary aim was to evaluate the value of these param-
eters in differentiating pulmonary hemodynamic patterns in 
patients with either confirmed PH or at risk for PH develop-
ment compared to an age-matched control group.
Methods
The study was performed as the part of the multicentre pro-
ject [12, 13] and its protocol was reviewed and approved by 
the institutional ethics committees as a part of the SE 2020 
study (148-Comitato Etico Lazio-1, July 16, 2016; Clini-
cal trials.Gov Identifier NCT 030.49995). All patients gave 
informed consent to enter the study.
Study group
We included 142 subjects, 96 women, mean age 
55 ± 15 years (from 19 to 88) from six centers, without 
the contraindications to exercise referred to ESE for the 
assessment of exercise tolerance as well as for CAD diag-
nosis/exclusion. As PH group we examined 31 consecu-
tive patients with diagnosed, treated and monitored PH as 
confirmed with mPAP > 25 mmHg assessed by right heart 
catheterization whose were amenable to exercise tolerance 
assessment with ESE.
Into PH risk group we included 61 subjects with systemic 
sclerosis (56 subjects) or mixed connective tissue disease 
(five patients) and as a control group 50 age-matched sub-
jects without risk factors of PH but with present risk fac-
tors for cardiovascular disease although without diagnosed 
coronary artery disease. Additionally we evaluated also the 
group of 29 young, healthy subjects, without risk factors for 
cardiovascular diseases, whose data were used for establish-
ing the normal values of tested parameters (PVRI CO and 
ESE time based).
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Echocardiographic assessment
Transthoracic echocardiography at rest and ESE was per-
formed with E9 (GE, Vingmed, Norway) or VIVID 7 (GE 
Vingmed Ultrasound AS, Horten, Norway) systems using 
M4S/M5S probes. During the echocardiography an ECG 
tracing was displayed on the monitor. The echocardiographic 
measurements (including Doppler parameters) were taken 
following the recommendations [6, 14–16].
Assessment of TRV and ACT 
TRV was derived with continuous wave Doppler from the 
apical four chamber or the parasternal right ventricular 
inflow view. The right ventricular systolic pressure was 
assumed to equal SPAP, and was calculated with the Ber-
noulli equation (TRV in m/s): SPAP = 4  TRV2 + right atrial 
pressure (RAP). RAP was estimated from the inferior vena 
cava (IVC) diameter and collapsing during the inspiration. 
We added RAP of 3 mm Hg (IVC diameter < 2.1 cm, col-
lapsing > 50% with a sniff), or 15 mm Hg (diameter > 2.1 cm, 
collapsing ≤ 50% with a sniff) or 8 mm Hg in mixed scenar-
ios. The value calculated at rest was applied also at stress 
[6, 17].
ACT was measured in right ventricular outflow tract as 
the time (in milliseconds) from the beginning of pulmonary 
ejection until the peak value of systolic velocity. Pulsed wave 
Doppler was used with sample positioned at the annulus of 
the pulmonary artery, in the parasternal short axis or in the 
subcostal view. The normal value is > 110 ms, the abnor-
mal < 105, and indeterminate—between 105 and 110 ms 
[18]. From the raw data of ACT, SPAP was derived on the 
basis of the correlation linking ACT to TRV as follows:  log10 
SPAP = − 0.004 (ACT) + 2.1 [19].
Exercise stress echocardiography
All patients underwent semi-supine bicycle ESE as 
described by recent recommendations [14]. The study 
protocol combining TRV and ACT assessment (TRACT) 
is displayed in Fig. 1. ESE was performed at an initial 
workload of 25 Watts lasting for 2 min, then the work-
load increased stepwise by 25 Watts at 2-min intervals. 
Electrocardiogram and blood pressure were monitored 
and all studies were performed by cardiologists experi-
enced in different kind of stress echo examinations and 
analysis assisted by the nurses or the doctors. Criteria for 
interrupting the test were chest pain, induced wall motion 
abnormalities, significant rhythm disturbances, excessive 
fatigue, blood pressure increase (systolic ≥ 240 mmHg, 
diastolic ≥ 120 mmHg), limiting dyspnea, legs pain or 
predicted heart rate. Video loops of heart cycles were 
acquired and digitally stored for further analysis. All 
echocardiographers had passed quality control of reading 
examinations as required by Stress Echo 2020 study with 
interobserver reproducibility ≥ 90% [20]. CO was derived 
Fig. 1  The study protocol 
with assessment of TRV and 
ACT for SPAP estimation, and 
cardiac output with Doppler/2D 
method. Exercise time is also 
recorded. ACT acceleration 
time, BP blood pressure, CO 
cardiac output, CW continuous 
wave, ECG electrocardiogram, 
LVOT left ventricular outflow 
tract, PLAX parasternal long 
axis view, PW pulsed wave, SE 
stress echocardiography, TRACT 
acronym from tricuspid regur-
gitation/acceleration time, TRV 
tricuspid regurgitant velocity, 
VTI velocity time integral
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from the Doppler-estimated stroke volume (SV) using 
the velocity time integral of flow through the left ven-
tricular outflow tract [21–25]. Pulmonary vascular resist-
ance (PVR) was calculated using Abbas formula: PVR 
(Wood Units) = TRV (m/s)/VTI RVOT (cm) *10 + 0.16 and 
assessed separately in two time points at baseline and peak 
exercise [26, 27].
As relatively flow-independent SPAP derived parameter 
we modified and simplified those proposed by Claessens: 
SPAP/CO slope (requiring two points, rest and peak, and 
slope calculation) was modified into CO/peak SPAP*0.1; 
SPAP/exercise intensity was modified into ESE time/peak 
SPAP*0.1 [11]. Pulmonary vascular reserve index (PVRI) 
was estimated as CO-based (CO-PVRI) or as exercise-time-
based (ESE time-PVRI). ESE-time was defined as time in 
minutes from beginning to the peak of exercise. Higher val-
ues of these parameters may reflect better pulmonary vas-
cular reserve.
We added three figures as case-illustrating graphics. 
Figure 2 presents TRV and ACT rest and stress measure-
ments done in healthy 43-old-year female whereas in Fig. 3 
respective parameters are displayed in 63-year-old man with 
diagnosed pulmonary hypertension. Figure 4 illustrates the 
comparison of PVRI expressed as slopes of delta SPAP in 
relations to ESE time. The lines illustrate respectively an 
normal flat response (with high PVRI) and a steep impaired 
response, with low PVRI value.
Statistical analysis
Data are expressed as mean ± standard deviation for con-
tinuous or frequency for categorical data. The distribution 
was assessed with the D’Agostino-Pearson test and adequate 
tests were used. For correlation Pearson’s or Spearman coef-
ficients were calculated. The comparisons were performed 
with t-test for independent samples or paired t-test, Wil-
coxon test or chi-squared test for categorical data. Statistical 
significance was set at p < 0.05. ROC analysis was applied 
for detection of cut-off values for studied parameters. Analy-
ses were conducted with MedCalc V. 12.1.4. (Frank Schoon-
jans Belgium).
Results
The clinical characteristics and hemodynamic data related 
to ESE of the patients and controls are listed in Table 1. In 
patients with diagnosed PH 11 had idiopathic PAH, 8 con-
genital heart disease related PH, 6 connective tissue related 
PH and 6 chronic thromboembolic PH. In PH at risk group, 
Fig. 2  Graphic presentation of TRV and ACT measurements at baseline and peak stress in 43-year-old woman with very good exercise tolerance 
and high normal PVRI, calculated as the ratio of ESE time and ΔSPAP in tens; PVRI = 14 min/1.3 = 10.8
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associated disease was systemic sclerosis in 56 patients, and 
mixed connective tissue disease in five patients.
The groups did not differ according to mean age, body 
mass index and the prevalence of hypertension and dia-
betes, nevertheless in PH risk group higher prevalence of 
women as well as smaller mean body surface area were 
observed. Contrary to both PH at risk and control group 
no patients with confirmed PH smoked.
The achieved workload as well as exercise duration 
(10.6 ± 3.3 vs 6.4 ± 1.9 vs 5.6 ± 1.6 min) were greater 
in controls as compared with PH risk and PH and was 
Fig. 3  Graphic presentation of TRV and ACT measurements at baseline and peak stress in 63-year-old man with poor exercise tolerance and 
highly abnormal PVRI, calculated as the ratio of ESE time and ΔSPAP in tens; PVRI = 3 min/3.5 = 0.9
Fig. 4  Graphic comparison 
of PVRI data representive 
for healthy subject with high 
value of PVRI and flat increase 
of SPAP during exercise and 
abnormal steep time—pressure 
relationship in patient with PH 
of diagnosed chronić thrombo-
embolic origin
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reflected also in more elevated peak systolic pressure 
(182 ± 31 vs 161 ± 25 vs 157 ± 30 mmHg).
For the variability assessment of echocardiographic 
parameters we calculated intraclass correlation coefficient. 
Intraobserver variability achieved for ACT at rest 0.96 and 
for TRV 0.99, whereas for the peak parameters these val-
ues were 0.89 for ACT and 0.96 for TRV, as we previously 
reported [9].
In Table 2 the feasibility of echocardiographic parameters 
is displayed showing for peak of ESE 44% of TRV feasi-
bility, 77% for ACT and 95% for SPAP estimation based 
on both TRV and ACT according to TRACT protocol. 
Similarly, the application of ESE time in the place of CO 
enabled the significant feasibility improvement of PVRI 
from 65 to 95%, p < 0.0001, see Fig. 5.
In Table 3 the comparison of echocardiographic param-
eters in all three groups showed the consistent differences 
for parameters reflecting pulmonary pressure, resistance and 
reserve indicating the most advanced impairment of pul-
monary circulation status in PH group, intermediate stage 
in PH risk patients and normal or near-normal values in 
age-matched controls. Additionally we estimated also the 
both PVRI parameters in 29 healthy, young patients (mean 
age 32 ± 5.3 years, 21 males, cardiovascular risk factors 
Table 1  Clinical and hemodynamics characteristics of the patients
ACE-I inhibitors of angiotensin converting enzyme, BSA body surface area, CCB calcium channel blockers, PH pulmonary arterial hypertension, 
DBP diastolic blood pressure, SBP systolic blood pressure, HR heart rate, PH pulmonary arterial hypertension
Variable Group 1
PH, N = 31
Group 2
PH risk, N = 61
Group 3



































Hypertension 13 (42%) 30 (49%) 17 (34%) ns ns ns
Diabetes 3 (10%) 4 (5%) 2 (4%) ns ns ns
Smoking 0 (0%) 18 (30%) 8 (16%) 0.0017 ns 0.0497
ACE-I 13 (42%) 13 (21%) 15 (30%) ns ns ns
CCB 5 (16%) 20 (33%) 3 (6%) ns 0.0012 ns
Diuretics 22 (71%) 22 (36%) 7 (14%) 0.0031 0.016  < 0.0001
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including smoking and obesity excluded) obtaining refer-
ence, normal values of 5.26 ± 2.9 L/min/mmHg for CO-
based PVRI and 5.03 ± 2.59 (min/mmHg) for ESE time-
based PVRI.
Moreover, in the analysis focused on the comparison 
between patients at risk of PH and controls (group 2 and 
3) all resting parameters: TRV, ACT, SPAP and PVR were 
similar in both compared groups, whereas variables meas-
ured at peak stage of ESE (apart from pulmonary vascular 
resistance, PVR) revealed higher values of TRV and SPAP 
and shorter ACT in patient with risk factors for PH, as well 
as significantly higher PVRI (either CO-based or exercise-
time-based) in controls, see Fig. 6.
Having the subgroup of invasively proved diagnosis of PH 
(31 patients) we estimated from ROC analysis cut-off values 
for flow dependent and independent parameters. The results 
are displayed in Table 4. Estimated cut-off values were tested 
in group at risk of PH development. The best cut-off values 
were: > 62 mmHg for SPAP, TRV-based; > 69 mmHg for 
SPAP, TRACT-based; ≤ 1.29 for CO-based PVRI; and ≤ 1 
for ESE time- based PVRI.
Moreover, we tried to estimate also the cut offs for diag-
nosis PH risk patients among subgroup consisted of PH at 
risk and age –matched controls and found the values ≤ 1.9 
for CO-based PVRI; and ≤ 1.7 for ESE time- based PVRI 
with respective ROC AUC of 0.917 and 0.824.
The relationship between peak SPAP calculated accord-
ing to TRACT approach and ESE-time based PVRI is dis-
played in Fig. 7 illustrating non-linear relationship between 
both parameters and high discriminatory value for three 
examined subgroups.
Discussion
Noninvasive estimates of PVRI expressed as indices based 
on CO or exercise-time can be obtained during exercise with 
moderate (CO-based) or excellent (ESE-time based) suc-
cess rate, achieving 95% feasibility for simplified data when 
avoiding CO calculation and utilizing beside TRV also ACT 
for SPAP calculation, Fig. 5. These PVRI parameters allow 
a clear discrimination of patients with PH or at risk for PH 
development as compared to control subjects as shown in 
Figs. 6 and 7. The significance of the pulmonary hemody-
namic assessment at peak stress was especially pronounced 
when applied for detection of patients at risk of PH, reveal-
ing similar values as controls at rest, see Fig. 6. The appli-
cation of indexed to flow indices seems to be more specific 
for accurate comparison of pulmonary vascular function 
between patients achieving highly varied level of exercise 
and related with this different peak cardiac output. In our 
study we observed significant percentage of patients achiev-
ing peak SPAP values between 40 and 60 mmHg for which 
more flow independent indices seem to offer important addi-
tional discriminating value, see Fig. 7. The flow correction 
can be obtained with Doppler-based measurement of stroke 
volume and CO (which is the recommended method for the 
Table 2  Echocardiographic findings: feasibility expressed as number 
and percentage
CO cardiac output, ESE exercise stress echocardiography, PV resist-
ance pulmonary vascular resistance, calculated according to Abbas 
formula: PV Resistance (Wood Units) = TRV (m/s)/VTI RVOT (cm) 
*10 + 0.16. PVRI pulmonary vascular reserve index, TRV tricuspid 
regurgitant velocity, ACT acceleration time of pulmonary flow, SPAP 
systolic pulmonary artery pressure
Parameter Number in the 
whole group of 
142 pts
(%) in the 
whole group
Rest TRV 80 56
Rest ACT 117 82
Peak TRV 62 44
Peak ACT 109 77
SPAP (TRV based) rest 80 56
SPAP (TRV based) peak 62 44
SPAP rest (TRV + ACT based) 138 97
SPAP peak (TRV + ACT based) 135 95
PV Resistance rest (Wood U) 79 56
PV Resistance peak (Wood U) 60 42
CO-based PVRI 92 65
ESE time- based PVRI 135 95
Fig. 5  Graphic presentation of the feasibility of echocardiographic 
parameters in the whole studied group. Including the ACT as an alter-
native parameters for SPAP estimation increased feasibility of stress 
SPAP obtaining from 44 to 95%. Similarly, the substitution of CO 
with ESE time increased feasibility for flow-independent indices from 
65 to 95%. ACT acceleration time, CO cardiac output, ESE exercise 
stress echocardiography, PVRI pulmonary vascular reserve index, 
SPAP systolic pulmonary artery pressure, TRV tricuspid regurgitant 
velocity. Blue colour—feasible data, white—unfeasible data; feasibil-
ity results: Peak SPAP (TRV based) = 44%, Peak SPAP (TRV + ACT 
based) = 95% CO based PVRI = 65%, ESE time-based PVRI = 95%
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estimation of CO in echocardiography) or with the means 
of volumetric only 2D assessment of the left ventricle, but 
without detectable loss of information also with achieved 
workload or simpler exercise-time, an imaging independent 
proxy of cardiac output.
Comparison with previous studies
Several studies have shown the value of ACT for evaluation 
of pulmonary pressures (mean PA or SPAP) when TRV is 
not available, which happens frequently especially at peak 
exercise [8, 16, 28]. Our data are also consistent with previ-
ous evidences showing that pulmonary vascular resistance 
and reserve may be more informative than SPAP in identify-
ing initial alterations of pulmonary hemodynamics [29, 30]. 
Simplified relationship between SPAP and exercise intensity 
have similar accuracy compared to direct measurements of 
CO in identifying an abnormal pulmonary vascular reserve, 
as shown by Claessens et al. in patients undergoing a simul-
taneous invasive assessment of pulmonary pressures [11]. In 
their study, an abnormal pulmonary reserve was identified as 
mPAP/CO slope by exercise CMR with invasive assessment 
of pressures. This method has superb accuracy but limited 
appeal in the clinical arena due to invasiveness and cost.
Yet, the noninvasive parameters which we proposed 
offered simple and highly accurate cut-offs for identification 
of PH patients with CO-based PVRI ≤ 1.29 and time-based 
PVRI ≤ 1 reflecting in an intuitive manner severely limited 
PVR, whereas the respective values ≤ 1.9 and ≤ 1.7 may 
indicate on early stage of pulmonary hypertension in which 
resting parameters are still near-normal. The availability of 
a highly feasible and simplified index is the prerequisite for 
large scale multicenter testing in the clinical arena [12, 13, 
20].
Clinical implications
Pulmonary hemodynamics is of utmost importance in the 
diagnosis, risk stratification and treatment in many cardio-
vascular conditions, from heart failure to pulmonary hyper-
tension, extreme physiology and congenital heart disease 
[31, 32] with Doppler echocardiography being the most 
widely used screening tool in current clinical practice [14].
Yet, the noninvasive assessment of pulmonary hemo-
dynamics with ESE does not find a relevant place in 
Table 3  Echocardiographic data comparison
ACT acceleration time of pulmonary flow, CO cardiac output, ESE exercise stress echocardiography, N’ number of feasible measurements, PV 


















 < 0.0001 ns  < 0.0001






 < 0.0001 ns  < 0.0001






 < 0.0001 0.0001  < 0.0001






 < 0.0001 0.0238  < 0.0001






 < 0.0001 0.0137  < 0.0001






 < 0.0001 0.0021  < 0.0001






 < 0.0001 ns  < 0.0001






 < 0.0001 0.0001  < 0.0001






 < 0.0001 ns  < 0.0001






 < 0.0001 ns  < 0.0001






0.034  < 0.0001  < 0.0001






 < 0.0001  < 0.0001  < 0.0001
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evidence-based recommendations, in spite of the recognized 
conceptual merits of evaluating hemodynamics during stress 
which can unmask early disease [33]. European Society of 
Cardiology 2015 guidelines on pulmonary hypertension 
clearly state that "exercise echo has technical and methodo-
logical limitations and is NOT recommended for PH/PAH 
screening" (class of evidence III, level of recommendation 
C) [2]. More recently, the 2019 European Society of Car-
diology consensus recommendations on heart failure with 
preserved ejection fraction propose ESE with diastolic stress 
test in patients with intermediate probability on the basis of 
resting functional, morphologic and biochemical criteria, 
but also specify that peak TRV is only feasible in 50% of 
patients, cannot be used as a stand-alone criterion due to 
Fig. 6  The subgroup analysis- comparison between patients at risk of 
PH and controls. Bar graph showing the separation of the subgroup 
PH risk and controls, empty columns only by indices measured at 
peak ESE and pulmonary vascular reserve index. From left to right: 
TRV rest; TRV peak, (cm/s) ACT; rest, ACT peak (ms), SPAP rest, 
SPAP peak (mmHg), CO-based PVRI (CO/SPAP*10–1) (l/min/
mmHg); ESE time-based PVRI (ESE time/SPAP*10–1) (min/mmHg). 
ACT acceleration time, CO cardiac output, ESE exercise stress echo-
cardiography, PVRI pulmonary vascular reserve index, SPAP systolic 
pulmonary artery pressure, TRV tricuspid regurgitant velocity
Table 4  Diagnostic value and 
cut- offs for flow dependent and 
independent parameters in the 
diagnosis of confirmed PH, the 
results of the ROC analysis
ACT acceleration time of pulmonary flow, AUC area under curve, CO cardiac output, ESE exercise stress 
echocardiography, PVRI pulmonary vascular reserve index, SPAP systolic pulmonary artery pressure, TRV 
tricuspid regurgitant velocity
Parameter AUC Cut-off value Sensitivity Specificity
SPAP (TRV based) stress (mmHg) 0.964  > 62 96% 89%
SPAP (TRV + ACT based) stress (mmHg) 0.935  > 69 87% 98%
CO-based PVRI (L/min/mmHg) 0.922  ≤ 1.29 84% 95%
ESE time-based PVRI (min/mmHg) 0.949  ≤ 1.0 87% 91%
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its flow-dependence, and a peak TRV > 3.4 m/s has some 
diagnostic value only when accompanied by E/e′ > 15 dur-
ing exercise stress [34]. At least in principle, exercise-time 
based PVRI approach might remove the feasibility and con-
ceptual barriers currently limiting an extensive ESE use in 
the clinical arena.
Despite its present limitations and with accordance to 
recent guidelines [2, 14] exercise stress echocardiography 
with noninvasive assessment of pulmonary pressure, resist-
ance and right ventricular function should be considered in 
patients at high risk for PAH development as the adjunct 
tool exceeding the diagnostic potential of rest-only examina-
tion. Similarly, in patients with the established diagnosis of 
PH, not showing the contraindications to exercise, noninva-
sive but quantitative assessment could improve monitoring 
of treatment and help further in prognostic stratification. 
Moreover, there are data showing that ESE, beyond the more 
technically demanding hypoxic challenge, may predict the 
risk of chronic mountain sickness (CMS) and high altitude 
pulmonary edema (HAPE) appearance [35]. Additionally, 
the adding the pulmonary parameters to the assessment of 
so called „diastolic stress echo” have a potential for more 
detailed stratification of these the most prevalent etiology 
of „secondary” PH [10], see Fig. 8 displaying the proposed 
role of the exercise stress in PH diagnosis.
Fig. 7  The relationship between ESE-time based pulmonary vascular 
reserve index and SPAP achieved at peak ESE, showing clear separa-
tion of controls (green circles) and patients with confirmed PH (red 
circles). As far as group at risk of PH is concerned (orange squares) 
two patients showed SPAP at peak > 69 mmHg whereas 11 patients 
displayed lowered pulmonary vascular reserve < 1 min/mmHg, which 
suggests higher sensitivity of this parameter for detection of early 
stage of pulmonary hemodynamics impairment. ESE exercise stress 
echocardiography, PVRI pulmonary vascular reserve index, SPAP 
systolic pulmonary artery pressure, TRACT acronym for using TRV 
and ACT for SPAP estimation, vertical line indicates cut-off for SPAP 
69  mmHg, horizontal line cut-off value for ESE time-based PRVI 
1  min/mmHg, green circles—controls, orange squares—patients at 
risk of PH, red circles—patients with confirmed PH
Fig. 8  Proposed role of the 
exercise stress in PH diagnosis. 
BNP brain natriuretic pep-
tide, CMS chronic mountain 
sickness, HAPE high altitude 
pulmonary edema, HFPEF 
heart failure with preserved 
ejection fraction, PAH pulmo-
nary arterial hypertension, PH 
pulmonary hypertension, TRV 
tricuspid regurgitant velocity, 
TTE transthoracic echocardiog-
raphy, 6MWT six minute walk 
test
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Limitations
Groups were not homogeneous, in particular with higher 
prevalence of women in the group of PH risk, due to the well 
known epidemiological profile of connective tissue disease. 
However, the pulmonary pressure response during exercise 
seems to be similar between men and women as has been 
recently published in metaanalysis of studies basing on right 
heart catheterisation [36]. Other possible confounders are 
intergroup inhomogeneities in BSA, smoking and cardio-
vascular drug usage, unavoidable when comparing group 
with different female to male ratio as well as different health 
status. However, the primary aim of the study concerning 
the feasibility assessment of the new proposed method, was 
unlikely affected by these confounders.
TRV and ACT have recognized limitations in the assess-
ment of SPAP, including inadequate validation during exer-
cise, need to include during exercise right atrial pressure 
typically assumed from inferior vena cava dimension and 
collapsibility at rest, possible heart rate-dependence for 
ACT.
The echocardiographers were not blinded to the study 
condition since the increased heart rate is associated with 
peak exercise. Also the acquisition of both parameters 
was not simultaneous but data were recorded in sequential 
manner.
Finally, we did not use saline microbubble injection as 
an attempt to enhance TRV spectrum since this maneuver 
requires intravenous injections and further complication of 
an already technically demanding ESE study.
Conclusion
Patients at risk for PH can be effectively separated from 
controls using transthoracic echocardiographic assess-
ment during ESE. To achieve this clinically important goal, 
flow-independent indices such as CO-based PVRI or exer-
cise time-based PVRI may be more effective than resting 
or stress indices such as SPAP. The feasibility of assessing 
PVRI is excellent if SPAP is obtained combining TRV or 
ACT, whenever TRV is not feasible, along with imaging-
independent exercise-time used as a simple proxy of CO. 
This integrated approach allows to increase the success rate 
close to 100% and to adopt a more robust and more flow-
independent assessment of pulmonary hemodynamics into 
practice.
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